LEXINGTON, Mass.--(BUSINESS WIRE)-- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that members of management will be participating in the following investor conferences:
- Morgan Stanley Global Healthcare Conference, September 14 at 2:10 p.m. ET in New York City
- UBS Global Life Sciences Conference, September 19 at 8:00 a.m. ET in New York City
A live webcast of each presentation will be accessible through the Investors section of the company’s website at www.amagpharma.com. Following each conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for approximately two weeks.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit www.amagpharma.com.
CONTACT:
AMAG Pharmaceuticals, Inc.
Carol Miceli, 617-498-3361
KEYWORDS: United States North America Massachusetts New York
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical
MEDIA: